Carboplatin Periocular Injection for Retinoblastoma
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the clinical efficacy of periocular injections of carboplatin
together with chemotherapy in the treatment of Retinoblastoma as compared to chemotherapy
alone.